Real‐world pharmacovigilance assessment of drug‐induced male hypogonadism risks: An analysis of FDA adverse drug event data

Documenti analoghi

• Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism
  di: Martin Miner, et al.
  Pubblicazione: (2024)
• Maternal use of nitrosatable drugs during pregnancy and adult male reproductive health: A population‐based cohort study
  di: Pernille Jul Clemmensen, et al.
  Pubblicazione: (2024)
• Single‐arm study of testosterone gel replacement therapy and ambulatory blood pressure outcomes in men with hypogonadism
  di: Michael A. Weber, et al.
  Pubblicazione: (2024)
• Shared risk and shared responsibility: the ethics of male contraceptives
  di: Georgina D. Campelia, et al.
  Pubblicazione: (2024)
• Identification of potential drug targets for erectile dysfunction with single‐cell RNA sequencing: A Mendelian randomization study
  di: Bo‐yu Xiang, et al.
  Pubblicazione: (2025)